Trial intelligence / Profile preview

Remimazolam vs propofol for sedation and analgesia in ICU patients with cardiac insufficiency

ChiCTR2200065895Phase 4Recruiting

Sponsor
Renshou County People's Hospital
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of remimazolam in heart failure (HF) (2 arms), sponsored by Renshou County People's Hospital. Primary endpoints: Analgesia sedation delirium score, Respiratory support mode and 2 more. Started Nov 2022; status: recruiting.

02

Drugs

remimazolam
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on ChiCTR2200065895.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200065895.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call